📢 New study alert! Introducing FIRE-Xa: Exploring outcomes of ICH patients on Factor Xa inhibitors. Now enrolling at University Hospitals Bern, Basel, Zürich, Klinik Hirslanden, and Kantonsspital St. Gallen. David Seiffge Stroke Research Center Bern FIRE-Xa_Trial

🚨 New ELAPSE Trial Site Alert! 🚨 The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne has officially opened today as the newest site in Switzerland for the ELAPSE trial and is now recruiting patients! Stroke Research Center Bern Lorenz Räber, MD PhD Urs Martin Fischer David Seiffge

Kudos to the authors for pinpointing this important principle, will be a citation classic.

Basilar Artery Perforator Aneurysms – The Phantom Menace of the Intracranial Universe journals.sagepub.com/doi/10.1177/15… A new video on a rare subtype of intracranial aneurysms. Should you encounter such aneurysms, please consider joining our registry. Tomas Dobrocky Stroke Research Center Bern Johannes Goldberg

🎨 Perfusion imaging post-EVT 🎨 Microvascular hypoperfusion may explain poor outcome despite TICI3 ⬇️ ahajournals.org/doi/10.1161/ST… Eike Piechowiak Thomas Meinel Tomas Dobrocky David Seiffge Martina Göldlin Eva A. Mistry, MBBS, MSCI, FAHA Urs Martin Fischer Susanne Wegener Johannes Kaesmacher Stroke Research Center Bern Faculty of Medicine, University of Bern

Congratulations Adnan Mujanović on your successful PhD defense! This achievement is the culmination of years of hard work, dedication, and perseverance. Your personality and contributions are a big asset for Stroke Research Center Bern and we are looking forward to the years to come with you 💪

🚨ELAPSE Trial Site Alert🚨 The Kantonsspital St. Gallen has officially opened as the newest site in Switzerland for the ELAPSE trial and is now recruiting patients! Exciting step forward for stroke research!🧠 Stroke Research Center Bern Lorenz Räber, MD PhD Urs Martin Fischer David Seiffge Gian Marco De Marchis, MD MSc

Interresting paper: how to treat „breakthrough“ stroke despite anticoagulation in patients with AFib? DOACs best, changing/switching is just psychology. Still high recurrence rate, better treatments needed ELAPSE Urs Martin Fischer Lorenz Räber, MD PhD Stroke Research Center Bern Christian H Nolte

It was a pleasure having you, Farid Abedrabbo 🇪🇨 ! Always well prepared, kind and skilful! You even mastered Swiss German! Thanks to European Academy of Neurology for making this possible! Stroke Research Center Bern European Stroke Master Urs Martin Fischer Thomas Meinel

🎉Exciting news🎉 We're pleased to announce the expansion of the FIRE-Xa trial with the official opening of our newest site Luzerner Kantonsspital in 🇨🇭. A big thank you to Manuel Bolognese and his study team for making this possible. FIRE-Xa_Trial Stroke Research Center Bern David Seiffge

Latest updates in the gudielines of ICH management 🧠🩸by Bernhard Siepen at Bern Stroke & Brain Health Symposium. Andexanet alfa in DOAC-associated ICH showed lower rates of HE - but this did not translate into better functional outcome ❌️

More and more stroke patients are benefiting from EVT 📊 Philipe Breiding from Stroke Research Center Bern presented latest updates among patients with large-core (NNT with EVT: 5) as well as patients in the late window ✅️

Thank you Edip Gurol for your insightful presentation on #LAAO at our 2024 #Stroke Symposium Stroke Research Center Bern! Looking forward to future collaborations! 🇺🇲🇨🇭🧠❤️🫀 David Seiffge Urs Martin Fischer

Stroke Winter School in Bern - a living legend!